Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Newron Initiates First Potentially Pivotal Study with Evenamide in Patients with Schizophrenia
Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of […]
Drug Could Help Hearts Recover After Heart Attack
A drug used to treat certain cancers could improve recovery after a heart attack by […]
NeuExcell Therapeutics and Spark Therapeutics Announce Research Collaboration Agreement to Develop a Novel Gene Therapy for Huntington's Disease
NeuExcell Therapeutics and Spark Therapeutics, a member of the Roche Group (SIX: RO, ROG;OTCQX: RHHBY) today announced a […]
Swiss Medtech Bloom Diagnostics Company Opens its First Flagship Store in Zurich
Swiss medtech company Bloom Diagnostics has, today, opened its first-ever flagship store at a busy […]
Additional £5.4 Billion for NHS Covid Response Over Next Six Months
The NHS will receive an extra £5.4 billion over the next six months to support […]
Pfizer Announces Start of Phase 3 Clinical Trial in Adults for its Investigational Vaccine Against Respiratory Syncytial Virus (RSV)
Pfizer Inc. (NYSE:PFE) today announced the initiation of RENOIR (RSV vaccine Efficacy study iNOlder adults Immunized against RSV […]
NHS to Diagnose Thousands of People with Rare Diabetes
Genetic testing on the NHS will spot a rare form of diabetes in thousands of […]
NuvoAir Respiratory Platform Shows Promise for Long-Term Remote Monitoring of Asthma
Three new studies show how home monitoring technology – developed by leading digital health company NuvoAir – […]
New Study to Test Third COVID-19 Vaccine for People with Weakened Immune Systems
A new clinical trial to determine whether a third dose of vaccine will improve the […]
Q’Apel Medical Launches Armadillo – A New Radial Artery Access Platform to Meet the Needs of Physicians and Patients
Q’Apel Medical, Inc., an innovative neurovascular company specializing in developing and commercializing novel access device […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more